跳到正文
PR Newswire 健康·· 3 小时前AI 评分27

ScreenPoint Medical 任命 Parul Sharma 为首席商务官

ScreenPoint Medical Appoints Parul Sharma as Chief Commercial Officer

AI 导读

ScreenPoint Medical 任命 Parul Sharma 为首席商务官,负责其全球市场推广战略与执行,覆盖销售、市场、客户成功、合作和收入运营。她此前担任 Viedoc 首席商务官,并在 Hansoft、Besedo、Bannerflow 出任商业管理岗位。公司称其 Transpara 乳腺 AI 已在全球处理超过 1500 万张乳腺影像。

正文 · 原文

, /PRNewswire/ -- ScreenPoint Medical today announced the appointment of Parul Sharma to its Management Team as Chief Commercial Officer. As CCO, Parul  will lead the company's global go-to-market strategy and execution, spanning sales, marketing, customer success, partnerships and revenue operations.

Parul Sharma joins ScreenPoint Medical as Chief Commercial officer

Parul Sharma joins ScreenPoint Medical as Chief Commercial officer

Since 2016, Parul has served in C-level commercial leadership roles across a variety of software verticals, including positions at Hansoft, Besedo, and Bannerflow. Most recently, she served as Chief Commercial Officer at Viedoc, an Electronic Data Capture (EDC) platform for clinical trial data serving sponsors and study sites.She brings extensive experience in commercial leadership, revenue growth and scaling technology businesses.

"What attracted me to ScreenPoint Medical is the opportunity to bring together innovative technology and strong clinical evidence that translates into meaningful impact for women," said Parul Sharma, Chief Commercial Officer at ScreenPoint Medical. "I'm excited to work with this team to build on the company's global momentum, accelerate Transpara's adoption and bring the benefits of Breast AI to more healthcare providers and patients around the world."

This appointment reflects  significant global traction for the organization and increasing adoption of breast cancer AI solutions: with over 15 million mammograms processed worldwide to date, ScreenPoint Medical  has accelerated commercial momentum in the United States, Europe, and other markets over the past year and continues to lead in clinical research as part of landmark randomised controlled trials like MASAI, PRISM, and AIMS.

"Healthcare providers and programmes alike are rapidly adopting AI to unlock greater clinical impact for their patients and operational value for their practices ," said Pieter Kroese, CEO of ScreenPoint Medical. "Parul  has a proven track record of working alongside teams and organisations as they translate new technologies into tangible outcomes. I welcome her expertise to the team as we accelerate our next phase of growth."

Parul  received her undergraduate degree in Biochemistry from Delhi University and a postgraduate degree in Brand Management from Mudra Institute of Communications. She resides in Stockholm.

About ScreenPoint Medical

In the fight against breast cancer, every image is an opportunity: to unlock insight, to uncover risk, to embody health, to empower life. Proven through research, driven by innovation, and tailor-made for those seeking to lead in breast health, ScreenPoint's Transpara Breast AI is trusted by radiologists and women across the globe. We are Breast AI.

Media Contact:

Cameron D Bowman                                                                                
[email protected]                

SOURCE ScreenPoint Medical

来源:PR Newswire 健康 · prnewswire.com